Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

B. Schmalfeldt

h-index 50 View on Semantic Scholar

We have 4 of 493 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

Cervical cancer is caused by persistent high-risk human papillomavirus (HR-HPV) infection and remains a major global health burden despite available preventive strategies. Most HR-HPV infections and associated low-grade squamous intraepithelial lesions (LSIL) regress spontaneously, yet increasing commercial promotion o...

R. Pareja, F. Heredia, Emmanuel Sánchez-Díaz et al. · 0 citations
Sep 2026

FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

Cervical cancer is caused by persistent high-risk human papillomavirus (HR-HPV) infection and remains a major global health burden despite available preventive strategies. Most HR-HPV infections and associated low-grade squamous intraepithelial lesions (LSIL) regress spontaneously, yet increasing commercial promotion o...

R. Pareja, F. Heredia, Emmanuel Sánchez-Díaz et al. · 0 citations
Review Open access Oct 2026

Global implementation of hereditary cancer care in gynecologic oncology: Development and evaluation of the Hereditary Cancer Care Implementation Index.

This study develops and evaluates a pragmatic framework for benchmarking hereditary cancer care implementation in gynecologic oncology and identify gaps between testing access, policy adoption, and preventive care delivery to evaluate genetic counselor workforce capacity as an independent implementation correlate acros...

Mauricio A. Cuello, Carolina Ibañez, J. Obando et al. · 0 citations
Open access Aug 2026

Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer

A previously undescribed expression signature with potential predictive value for bevacizumab benefit is identified, and transcriptional heterogeneity of ovarian cancer that extends beyond current molecular classifications is revealed.

O. Zolotareva, K. Legler, O. Tsoy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.